Nitric oxide maintains dilation of immature and mature collaterals in rat hindlimb

Joseph L. Unthank, J. Craig Nixon, Michael Dalsing

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The role of nitric oxide (NO) in maintaining collateral dilation was investigated in rats with acute and chronic superficial femoral artery occlusion. Collateral function was evaluated from arterial pressure measurements proximal (mean arterial pressure, MAP) and distal (P(D)) to the occlusion under resting and hyperemic conditions. For resting and hyperemic conditions, respectively, P(D) increased with the duration of occlusion from 34 ± 2.1 and 14 ± 0.8 mm Hg acutely postocclusion to 37 ± 2.8 and 19 ± 3.6, 42 ± 4.9 and 25 ± 1.5, and 49 ± 5.6 and 25 ± 2.1 mm Hg at 1, 4, and 12 weeks. After NO synthase inhibition with Nω-nitro-L-arginine methyl ester (L-NAME), P(D) in control limbs increased but in occluded limbs decreased by 20 ± 2.0 mm Hg (acute) and 18 ± 2.1, 15 ± 4.4, and 20 ± 8.1 mm Hg at 1, 4, and 12 weeks postligation, respectively. The percent of MAP (%MAP) dissipated by large arteries and collateral vessels decreased during collateral development (from 71 ± 1.7% acutely to 57 ± 2.2% at 12 weeks postligation) and was increased ~20% by L-NAME at each time point. The rise in P(D) and decrease in %MAP dissipated by collaterals following chronic occlusion indicates that significant collateral development occurred. The fall in P(D) and increase in %MAP dissipation after L-NAME administration suggest that NO-mediated vasodilatory tone is maintained throughout the period of collateral development.

Original languageEnglish
Pages (from-to)471-479
Number of pages9
JournalJournal of Vascular Research
Volume33
Issue number6
StatePublished - Nov 1996

Fingerprint

Hindlimb
Dilatation
Arterial Pressure
Nitric Oxide
NG-Nitroarginine Methyl Ester
Extremities
Femoral Artery
Nitric Oxide Synthase
Arteries

Keywords

  • Collateral resistance
  • Immature collaterals
  • Mature collaterals
  • Nω-Nitro-L arginine methyl ester
  • Nitric oxide

ASJC Scopus subject areas

  • Physiology

Cite this

Nitric oxide maintains dilation of immature and mature collaterals in rat hindlimb. / Unthank, Joseph L.; Nixon, J. Craig; Dalsing, Michael.

In: Journal of Vascular Research, Vol. 33, No. 6, 11.1996, p. 471-479.

Research output: Contribution to journalArticle

@article{88543fac6bf54bbdb23b17d1f1975de0,
title = "Nitric oxide maintains dilation of immature and mature collaterals in rat hindlimb",
abstract = "The role of nitric oxide (NO) in maintaining collateral dilation was investigated in rats with acute and chronic superficial femoral artery occlusion. Collateral function was evaluated from arterial pressure measurements proximal (mean arterial pressure, MAP) and distal (P(D)) to the occlusion under resting and hyperemic conditions. For resting and hyperemic conditions, respectively, P(D) increased with the duration of occlusion from 34 ± 2.1 and 14 ± 0.8 mm Hg acutely postocclusion to 37 ± 2.8 and 19 ± 3.6, 42 ± 4.9 and 25 ± 1.5, and 49 ± 5.6 and 25 ± 2.1 mm Hg at 1, 4, and 12 weeks. After NO synthase inhibition with Nω-nitro-L-arginine methyl ester (L-NAME), P(D) in control limbs increased but in occluded limbs decreased by 20 ± 2.0 mm Hg (acute) and 18 ± 2.1, 15 ± 4.4, and 20 ± 8.1 mm Hg at 1, 4, and 12 weeks postligation, respectively. The percent of MAP ({\%}MAP) dissipated by large arteries and collateral vessels decreased during collateral development (from 71 ± 1.7{\%} acutely to 57 ± 2.2{\%} at 12 weeks postligation) and was increased ~20{\%} by L-NAME at each time point. The rise in P(D) and decrease in {\%}MAP dissipated by collaterals following chronic occlusion indicates that significant collateral development occurred. The fall in P(D) and increase in {\%}MAP dissipation after L-NAME administration suggest that NO-mediated vasodilatory tone is maintained throughout the period of collateral development.",
keywords = "Collateral resistance, Immature collaterals, Mature collaterals, Nω-Nitro-L arginine methyl ester, Nitric oxide",
author = "Unthank, {Joseph L.} and Nixon, {J. Craig} and Michael Dalsing",
year = "1996",
month = "11",
language = "English",
volume = "33",
pages = "471--479",
journal = "Journal of Vascular Research",
issn = "1018-1172",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Nitric oxide maintains dilation of immature and mature collaterals in rat hindlimb

AU - Unthank, Joseph L.

AU - Nixon, J. Craig

AU - Dalsing, Michael

PY - 1996/11

Y1 - 1996/11

N2 - The role of nitric oxide (NO) in maintaining collateral dilation was investigated in rats with acute and chronic superficial femoral artery occlusion. Collateral function was evaluated from arterial pressure measurements proximal (mean arterial pressure, MAP) and distal (P(D)) to the occlusion under resting and hyperemic conditions. For resting and hyperemic conditions, respectively, P(D) increased with the duration of occlusion from 34 ± 2.1 and 14 ± 0.8 mm Hg acutely postocclusion to 37 ± 2.8 and 19 ± 3.6, 42 ± 4.9 and 25 ± 1.5, and 49 ± 5.6 and 25 ± 2.1 mm Hg at 1, 4, and 12 weeks. After NO synthase inhibition with Nω-nitro-L-arginine methyl ester (L-NAME), P(D) in control limbs increased but in occluded limbs decreased by 20 ± 2.0 mm Hg (acute) and 18 ± 2.1, 15 ± 4.4, and 20 ± 8.1 mm Hg at 1, 4, and 12 weeks postligation, respectively. The percent of MAP (%MAP) dissipated by large arteries and collateral vessels decreased during collateral development (from 71 ± 1.7% acutely to 57 ± 2.2% at 12 weeks postligation) and was increased ~20% by L-NAME at each time point. The rise in P(D) and decrease in %MAP dissipated by collaterals following chronic occlusion indicates that significant collateral development occurred. The fall in P(D) and increase in %MAP dissipation after L-NAME administration suggest that NO-mediated vasodilatory tone is maintained throughout the period of collateral development.

AB - The role of nitric oxide (NO) in maintaining collateral dilation was investigated in rats with acute and chronic superficial femoral artery occlusion. Collateral function was evaluated from arterial pressure measurements proximal (mean arterial pressure, MAP) and distal (P(D)) to the occlusion under resting and hyperemic conditions. For resting and hyperemic conditions, respectively, P(D) increased with the duration of occlusion from 34 ± 2.1 and 14 ± 0.8 mm Hg acutely postocclusion to 37 ± 2.8 and 19 ± 3.6, 42 ± 4.9 and 25 ± 1.5, and 49 ± 5.6 and 25 ± 2.1 mm Hg at 1, 4, and 12 weeks. After NO synthase inhibition with Nω-nitro-L-arginine methyl ester (L-NAME), P(D) in control limbs increased but in occluded limbs decreased by 20 ± 2.0 mm Hg (acute) and 18 ± 2.1, 15 ± 4.4, and 20 ± 8.1 mm Hg at 1, 4, and 12 weeks postligation, respectively. The percent of MAP (%MAP) dissipated by large arteries and collateral vessels decreased during collateral development (from 71 ± 1.7% acutely to 57 ± 2.2% at 12 weeks postligation) and was increased ~20% by L-NAME at each time point. The rise in P(D) and decrease in %MAP dissipated by collaterals following chronic occlusion indicates that significant collateral development occurred. The fall in P(D) and increase in %MAP dissipation after L-NAME administration suggest that NO-mediated vasodilatory tone is maintained throughout the period of collateral development.

KW - Collateral resistance

KW - Immature collaterals

KW - Mature collaterals

KW - Nω-Nitro-L arginine methyl ester

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=0030444979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030444979&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 471

EP - 479

JO - Journal of Vascular Research

JF - Journal of Vascular Research

SN - 1018-1172

IS - 6

ER -